Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Xeroderma Pigmentosum × Clear all

Phase

Phase 2 3 Phase NA 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3803 Neoplasms 2952 Prostatic Neoplasms 1732 Colorectal Neoplasms 1412 Lung Neoplasms 1301 Motor Activity 789 Head and Neck Neoplasms 674 Pancreatic Neoplasms 654 Colonic Neoplasms 649 Uterine Cervical Neoplasms 635 Carcinoma, Hepatocellular 621 Carcinoma, Non-Small-Cell Lung 620 Rectal Neoplasms 565 Stomach Neoplasms 531 Brain Neoplasms 475 Ovarian Neoplasms 432 Pain 412 Anxiety Disorders 412 Neoplasm Metastasis 383 Esophageal Neoplasms 379 Polycystic Ovary Syndrome 370 Precursor Cell Lymphoblastic Leukemia-Lymphoma 352 Urinary Bladder Neoplasms 349 Fatigue 332 Melanoma 319 Multiple Myeloma 317 Lymphoma 305 Depression 300 Endometrial Neoplasms 285 Liver Neoplasms 278

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03445052 2020-07-22

XPAND

Guy's and St Thomas' NHS Foundation Trust

Phase NA Completed

Xeroderma Pigmentosum

Data powered by HemOnc (CC BY 4.0) Colophon ⚡